BRPI0409882A - compounds, pharmaceutical compositions, method for the treatment or prophylaxis of diseases, and uses of compounds and one or more compounds in combination with other pharmacologically active compounds - Google Patents
compounds, pharmaceutical compositions, method for the treatment or prophylaxis of diseases, and uses of compounds and one or more compounds in combination with other pharmacologically active compoundsInfo
- Publication number
- BRPI0409882A BRPI0409882A BRPI0409882-0A BRPI0409882A BRPI0409882A BR PI0409882 A BRPI0409882 A BR PI0409882A BR PI0409882 A BRPI0409882 A BR PI0409882A BR PI0409882 A BRPI0409882 A BR PI0409882A
- Authority
- BR
- Brazil
- Prior art keywords
- compounds
- pharmaceutical compositions
- diseases
- treatment
- combination
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/08—Bridged systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/10—Spiro-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Urology & Nephrology (AREA)
- Ophthalmology & Optometry (AREA)
- Endocrinology (AREA)
- Vascular Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Emergency Medicine (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Gynecology & Obstetrics (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
"COMPOSTOS, COMPOSIçõES FARMACêUTICAS, MéTODO PARA O TRATAMENTO OU PROFILAXIA DE DOENçAS, E, USOS DE COMPOSTOS E DE UM OU MAIS COMPOSTOS EM COMBINAçãO COM OUTROS COMPOSTOS FARMACOLOGICAMENTE ATIVOS". A invenção refere-se a novos derivados de 3,9-diazabiciclo¢3.3.!noneno e a compostos relacionados e a seu uso como ingredientes ativos na preparação de composições farmacêuticas. A invenção refere-se também a aspectos relacionados, incluindo processos para a preparação dos compostos, composições farmacêuticas contendo um ou mais destes compostos e, em especial a seu uso como inibidores de renina."COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, METHOD FOR TREATMENT OR PROPHYLAXY OF DISEASES, AND USES OF COMPOUNDS AND ONE OR MORE COMPOUNDS IN COMBINATION WITH OTHER PHARMACOLOGICALLY ACTIVE COMPOUNDS". The invention relates to novel 3,9-diazabicyclo [3.3] nonene derivatives and related compounds and their use as active ingredients in the preparation of pharmaceutical compositions. The invention also relates to related aspects, including processes for the preparation of the compounds, pharmaceutical compositions containing one or more of these compounds, and in particular their use as renin inhibitors.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP0304622 | 2003-05-02 | ||
PCT/EP2004/004372 WO2004096116A2 (en) | 2003-05-02 | 2004-04-26 | Diazabicyclononene derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0409882A true BRPI0409882A (en) | 2006-05-23 |
Family
ID=33395698
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0409882-0A BRPI0409882A (en) | 2003-05-02 | 2004-04-26 | compounds, pharmaceutical compositions, method for the treatment or prophylaxis of diseases, and uses of compounds and one or more compounds in combination with other pharmacologically active compounds |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP1622564A2 (en) |
JP (1) | JP2006525259A (en) |
KR (1) | KR20060015573A (en) |
CN (1) | CN1780838A (en) |
AU (1) | AU2004233577A1 (en) |
BR (1) | BRPI0409882A (en) |
CA (1) | CA2521898A1 (en) |
MX (1) | MXPA05011711A (en) |
RU (1) | RU2005137571A (en) |
WO (1) | WO2004096116A2 (en) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1867568A (en) * | 2003-10-13 | 2006-11-22 | 埃科特莱茵药品有限公司 | Diazabicyclononene derivatives and their use as renin inhibitors |
WO2005040173A1 (en) * | 2003-10-23 | 2005-05-06 | Actelion Pharmaceuticals Ltd | Diazabicyclononene and tetrahydropyridine derivatives as renin inhibitors |
AU2004295092A1 (en) * | 2003-12-05 | 2005-06-16 | Actelion Pharmaceuticals Ltd. | Azabicyclooctene and other tetrahydropyridine derivatives with a new side-chain |
AU2005276624B2 (en) | 2004-08-25 | 2011-09-29 | Actelion Pharmaceuticals Ltd. | Bicyclononene derivatives as renin inhibitors |
WO2006021403A1 (en) * | 2004-08-25 | 2006-03-02 | Actelion Pharmaceuticals Ltd | Bicyclononene derivatives |
WO2006058546A1 (en) * | 2004-12-01 | 2006-06-08 | Actelion Pharmaceuticals Ltd | Novel lactame derivatives as renin inhibitors |
WO2006063610A1 (en) * | 2004-12-17 | 2006-06-22 | Actelion Pharmaceuticals Ltd | Heteroaryl substituted diazabicyclononene derivatives |
GB0428526D0 (en) | 2004-12-30 | 2005-02-09 | Novartis Ag | Organic compounds |
JP4111533B1 (en) | 2005-01-28 | 2008-07-02 | アクテリオン ファーマシューティカルズ リミテッド | 7- {4- [2- (2,6-dichloro-4-methylphenoxy) ethoxy] phenyl} -3,9-diazabicyclo [3.3.31] as an inhibitor of renin for the treatment of hypertension Non-6-ene-6-carboxylic acid cyclopropyl- (2,3-dimethylbenzyl) amide |
WO2006131884A2 (en) * | 2005-06-07 | 2006-12-14 | Actelion Pharmaceuticals Ltd | Thiazole substituted diazabicyclononane or-nonene derivatives as renin inhibitors |
GB0514203D0 (en) | 2005-07-11 | 2005-08-17 | Novartis Ag | Organic compounds |
EP1968940B1 (en) | 2005-12-30 | 2014-04-02 | Novartis AG | 3 , 5-substitued piperidine compounds as renin inhibitors |
EP2007725A2 (en) * | 2006-03-16 | 2008-12-31 | Nicox S.A. | Non-peptidic renin inhibitors nitroderivatives |
EP2162436A4 (en) | 2007-05-24 | 2010-08-04 | Merck Frosst Canada Ltd | Novel case of renin inhibitors |
EP2527338B1 (en) | 2007-06-25 | 2015-05-06 | Novartis AG | N5-(2-ethoxyethyl)-n3-(2-pyridinyl) -3,5-piperidinedicarboxamide derivatives for use as renin inhibitors |
US8334308B2 (en) | 2007-08-20 | 2012-12-18 | Merck Sharp & Dohme Corp. | Renin inhibitors |
JP4790871B2 (en) | 2008-05-05 | 2011-10-12 | メルク フロスト カナダ リミテツド | 3,4-Substituted piperidine derivatives as renin inhibitors |
WO2013038936A1 (en) * | 2011-09-13 | 2013-03-21 | タカラバイオ株式会社 | Method for terminating peroxidase reaction, and terminating agent for said reaction |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3509161A (en) * | 1967-07-10 | 1970-04-28 | Boehringer & Soehne Gmbh | 3-phenyl-granatene-(2)-derivatives |
ATE242213T1 (en) * | 1995-09-07 | 2003-06-15 | Hoffmann La Roche | NEW 4-(OXYALKOXYPHENYL)-3-OXY-PIPERIDINE FOR THE TREATMENT OF HEART AND KIDNEY FAILURE |
BR0309498A (en) * | 2002-04-29 | 2005-02-15 | Actelion Pharmaceuticals Ltd | Compounds, pharmaceutical compositions, method for the treatment or prophylaxis of ras-related diseases, and use of compounds |
US20060009497A1 (en) * | 2002-06-27 | 2006-01-12 | Actelion Pharmaceuticals, Ltd. | Novel tetrahydropyridine derivatives as renin inhibitors |
-
2004
- 2004-04-26 AU AU2004233577A patent/AU2004233577A1/en not_active Abandoned
- 2004-04-26 CA CA002521898A patent/CA2521898A1/en not_active Abandoned
- 2004-04-26 RU RU2005137571/04A patent/RU2005137571A/en not_active Application Discontinuation
- 2004-04-26 WO PCT/EP2004/004372 patent/WO2004096116A2/en active Application Filing
- 2004-04-26 CN CNA2004800116500A patent/CN1780838A/en active Pending
- 2004-04-26 JP JP2006505261A patent/JP2006525259A/en active Pending
- 2004-04-26 MX MXPA05011711A patent/MXPA05011711A/en not_active Application Discontinuation
- 2004-04-26 EP EP04729414A patent/EP1622564A2/en not_active Withdrawn
- 2004-04-26 KR KR1020057020788A patent/KR20060015573A/en not_active Application Discontinuation
- 2004-04-26 BR BRPI0409882-0A patent/BRPI0409882A/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO2004096116A3 (en) | 2005-03-24 |
EP1622564A2 (en) | 2006-02-08 |
CN1780838A (en) | 2006-05-31 |
MXPA05011711A (en) | 2006-01-23 |
WO2004096116A2 (en) | 2004-11-11 |
AU2004233577A1 (en) | 2004-11-11 |
RU2005137571A (en) | 2006-05-10 |
CA2521898A1 (en) | 2004-11-11 |
KR20060015573A (en) | 2006-02-17 |
JP2006525259A (en) | 2006-11-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0409882A (en) | compounds, pharmaceutical compositions, method for the treatment or prophylaxis of diseases, and uses of compounds and one or more compounds in combination with other pharmacologically active compounds | |
BRPI0409884A (en) | compounds, pharmaceutical compositions, method for treating or porphyxia of diseases, and uses of compounds and one or more compounds in combination with other pharmacologically active compounds | |
BRPI0508540A (en) | compound, pharmaceutical composition, and use of a compound | |
BRPI0410477A (en) | compound or a pharmaceutically acceptable salt thereof, method for the prophylaxis or treatment of a chiral condition in a mammal, pharmaceutical formulation, combination, use of a compound, and process for preparing a compound | |
BR0309498A (en) | Compounds, pharmaceutical compositions, method for the treatment or prophylaxis of ras-related diseases, and use of compounds | |
BR0312000A (en) | Compounds, pharmaceutical compositions, method for treating or prophylaxis of diseases, and use of the compounds | |
BRPI0409818A (en) | compounds, pharmaceutical compositions, method for the treatment or prophylaxis of diseases, and uses of compounds and one or more compounds in combination with other pharmacologically active compounds | |
BRPI0513811A (en) | imidazo [4,5-d] pyrimidines, their uses and processes of preparation | |
BRPI0519280A2 (en) | compound, pharmaceutical composition and use of a compound | |
BRPI0307267B8 (en) | use of beta-lactamase inhibitor compounds and pharmaceutical compositions for antibacterial therapy | |
BR9911482A (en) | Compound, pharmaceutical composition, use of the compound, and, processes for the treatment or prophylaxis of inflammatory diseases, and for the preparation of a compound | |
NO20092529L (en) | Substituted 2,3-dihydroimidazo [1,2-c] quinazoline derivatives useful for the treatment of hyperproliferative disorders and diseases associated with angiogenesis | |
BR0213522A (en) | A compound, pharmaceutical composition, methods of inhibiting HIV integrase and for preventing or treating HIV infection or for preventing, treating or delaying the onset of AIDS in a patient, and useful combination for treating or preventing HIV infection or for preventing , treat or delay the onset of AIDS | |
BRPI0410563B8 (en) | pyrazol-quinazoline compounds, their preparation processes and pharmaceutical compositions | |
BR9907270A (en) | Compound, pharmaceutical composition, use of a compound, and, processes for the treatment or prophylaxis of inflammatory diseases, for example, asthma or copd, and for the preparation of a compound | |
BRPI0517634A (en) | thiazole derivative or a pharmaceutically acceptable derivative thereof, process for preparing a compound, pharmaceutical composition, use of a compound or pharmaceutically acceptable salt thereof, and method of treating a disease or condition | |
MXPA04012965A (en) | Viral inhibitors. | |
AR033367A1 (en) | IMIDAZOPIRIMIDINE DERIVATIVES AND TRIAZOLOPIRIMIDINE DERIVATIVES, A PROCEDURE FOR THEIR PREPARATION, MEDICINES, A PHARMACEUTICAL COMPOSITION, AND THE USE OF SUCH DERIVATIVES FOR THE PREPARATION OF MEDICINES | |
BR0114610A (en) | Compound Usage and Pharmaceutical Composition | |
DE602005021770D1 (en) | INDOLE-1-YL-ACETIC DERIVATIVES | |
BR0314353A (en) | Compounds, pharmaceutical compositions, use of one or more compounds in combination with other pharmacologically active compounds, and method for treating a patient suffering from a disorder. | |
BRPI0407253A (en) | Heterocyclyl-3-sulfonylindazoles as ligands 5-hydroxytryptamine-6 process for their preparation, their uses in the preparation of a pharmaceutical composition and a pharmaceutical composition comprising said compounds | |
BR0209518A (en) | New aryletheroalkylamine derivatives | |
BRPI0409878A (en) | compounds, pharmaceutical compositions, method for the treatment or prophylaxis of diseases, and uses of compounds and one or more compounds in combination with other pharmacologically active compounds | |
BR0309342A (en) | Compound, pharmaceutical composition, use of a compound, and method of treating or prophylaxis of human diseases or conditions. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B11A | Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing | ||
B11Y | Definitive dismissal acc. article 33 of ipl - extension of time limit for request of examination expired |